Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Henry

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Clinical Journal of Pain|August 29, 2022
Development and Testing of a Communication Intervention to Improve Chronic Pain Management in Primary Care: A Pilot Randomized Clinical TrialStephen G Henry, Joshua J Fenton, Cynthia I Campbell, et al.
Journal of General Internal Medicine|August 30, 2019
Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled TrialDavid D Odineal, Maria T Marois, Deborah Ward, et al.
Medical Care|October 11, 2021
A Risk Prediction Model for Long-term Prescription Opioid UseIraklis E Tseregounis, Daniel J Tancredi, Susan L Stewart, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|December 31, 2013
Patient-physician communication about early stage prostate cancer: analysis of overall visit structureStephen G Henry, Danielle Czarnecki, Valerie C Kahn, et al.
The International Journal on Drug Policy|October 19, 2019
Prescription drug monitoring programs operational characteristics and fatal heroin poisoningSilvia S Martins, William Ponicki, Nathan Smith, et al.
Addiction (Abingdon, England)|September 13, 2018
A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016Nathan Smith, Silvia S Martins, June Kim, et al.
Annals of Internal Medicine|May 26, 2018
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic ReviewDavid S Fink, Julia P Schleimer, Aaron Sarvet, et al.
Journal of General Internal Medicine|March 20, 2021
Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort StudyStephen G Henry, Susan L Stewart, Eryn Murphy, et al.
Journal of General Internal Medicine|October 4, 2023
Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort studyStephen G Henry, Shao-You Fang, Andrew J Crawford, et al.
The International Journal on Drug Policy|January 23, 2025
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scaleSamantha M Doonan, Katherine Wheeler-Martin, Corey Davis, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Clinical Journal of Pain|August 29, 2022
Development and Testing of a Communication Intervention to Improve Chronic Pain Management in Primary Care: A Pilot Randomized Clinical TrialStephen G Henry, Joshua J Fenton, Cynthia I Campbell, et al.
Journal of General Internal Medicine|August 30, 2019
Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled TrialDavid D Odineal, Maria T Marois, Deborah Ward, et al.
Medical Care|October 11, 2021
A Risk Prediction Model for Long-term Prescription Opioid UseIraklis E Tseregounis, Daniel J Tancredi, Susan L Stewart, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|December 31, 2013
Patient-physician communication about early stage prostate cancer: analysis of overall visit structureStephen G Henry, Danielle Czarnecki, Valerie C Kahn, et al.
The International Journal on Drug Policy|October 19, 2019
Prescription drug monitoring programs operational characteristics and fatal heroin poisoningSilvia S Martins, William Ponicki, Nathan Smith, et al.
Addiction (Abingdon, England)|September 13, 2018
A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016Nathan Smith, Silvia S Martins, June Kim, et al.
Annals of Internal Medicine|May 26, 2018
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic ReviewDavid S Fink, Julia P Schleimer, Aaron Sarvet, et al.
Journal of General Internal Medicine|March 20, 2021
Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort StudyStephen G Henry, Susan L Stewart, Eryn Murphy, et al.
Journal of General Internal Medicine|October 4, 2023
Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort studyStephen G Henry, Shao-You Fang, Andrew J Crawford, et al.
The International Journal on Drug Policy|January 23, 2025
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scaleSamantha M Doonan, Katherine Wheeler-Martin, Corey Davis, et al.
Pageof 8